primary antibodies against tnfsf14, hvem (Santa Cruz Biotechnology)
Structured Review

Primary Antibodies Against Tnfsf14, Hvem, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+hvem/primary+antibodies+against+tnfsf14++hvem/pmc07803499-130-22-42
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Tumor necrosis factor superfamily 14 is critical for the development of renal fibrosis"
Article Title: Tumor necrosis factor superfamily 14 is critical for the development of renal fibrosis
Journal: Aging (Albany NY)
doi: 10.18632/aging.104151
Figure Legend Snippet: Tnfsf14 deficiency ameliorates UUO-induced renal fibrosis. Kidney tissues from Tnfsf14 +/+ and Tnfsf14 −/− mice were collected at 7 days after UUO surgery. Sham group was used as the control of UUO. ( A ) Sirius Red and Masson staining of kidney tissues sections. Original magnification ×400. ( B ) α-SMA expression in kidney tissues was measured by immunohistochemistry. Original magnification ×200. ( C ) Western blot analyses of renal fibronectin and α-SMA expression in kidney tissues. Representative western blot (Left) and quantitative data (Right) are presented. ( D ) The mRNA levels of pro-fibrotic mediators Cola1 , Vim , and TGF-β1 were measured by qRT-PCR. The data were representative of the results of three independent experiments. All values are represented as mean ± SEM. n = 5 per group. ** P < 0.01 and * ** P < 0.001.
Techniques Used: Control, Staining, Expressing, Immunohistochemistry, Western Blot, Quantitative RT-PCR
Figure Legend Snippet: Sphk1 is critical for UUO-induced kidney fibrosis in mice. ( A ) Sphk1 expression in kidney tissues of Tnfsf14 +/+ mice after UUO surgery for 7 days was measured by immunohistochemistry (upper lane, original magnification ×200; lower lane, original magnification ×400). ( B ) Linear regression showed a close correlation between Sphk1 mRNA expression and Cola1 and Acta2 mRNA expression in kidney tissues of Tnfsf14 +/+ mice after UUO surgery for 7 days. Spearman’s correlation coefficient and P value are shown (n = 10). ( C – E ) After UUO surgery, PF543 (1 mg/kg/day) was injected intraperitoneally for consecutive 7 days, and then kidney tissues were collected from each group. ( C ) Sirius Red and Masson staining of kidney tissues sections. Original magnification ×400. ( D ) α-SMA expression in kidney tissues was measured by immunohistochemistry. Original magnification ×200. ( E ) Western blot analyses of renal fibronectin and α-SMA protein in kidney tissues. Representative western blot (Left and quantitative data (Right) are presented. Sham group was used as the control of UUO. The data were representative of the results of three independent experiments. All values are represented as means ± SEM. n = 5 per group. *** P < 0.001.
Techniques Used: Expressing, Immunohistochemistry, Injection, Staining, Western Blot, Control
Related Articles
Incubation:Article Title: High expression of herpes virus entry mediator is associated with poor prognosis in clear cell renal cell carcinoma Article Snippet: .. Briefly, sections (4-μm) were blocked with 5% BSA for 1 h at room temperature and incubated at 4°C overnight with primary Article Title: Improved Osteogenesis by HVEM-Expressing Allogenic Bone Marrow-Derived Mesenchymal Stem Cells in an Immune Activation Condition and Mouse Femoral Defect Model Article Snippet: Th is pa pe r h as b ee n pe er ‐re vie we d an d ac ce pt ed fo r p ub lic at io n, b ut h as ye t t o un de rg o co py ed iti ng an d pr oo f c or re ct io n. Th e f in al pu bl ish ed ve rs io n m ay d iff er fr om th is pr oo f. Improved osteogenesis by HVEM‐expressing allogenic bone marrow‐derived mesenchymal stem cells in an immune activation condition and mouse femoral defect model Zhigang Rong1, Fei Zhang2, Zhengdong Wang1, Weifeng He3, Shiwu Dong1,4, Jianzhong Xu1, Fei Dai1 1Department of Orthopaedics, National & Regional United Engineering Laboratory, Southwest Hospital, Army Medical University, Chongqing, China.. 2Department of Orthopaedics, General hospital of Xin Jiang military region, Xinjiang, China.. 3Institute of Burn Research, State Key Laboratory of Trauma, Southwest Hospital, Army Medical University, Chongqing, China. Article Title: Improved Osteogenesis by HVEM-Expressing Allogenic Bone Marrow-Derived Mesenchymal Stem Cells in an Immune Activation Condition and Mouse Femoral Defect Model. Article Snippet: Use of allogeneic mesenchymal stem cells (allo-MSCs) in bone tissue engineering strategies can overcome the limitations associated with autologous MSCs, but unfortunately, the immunogenicity of allo-MSCs leads to a high rate of rejection, unless immunosuppressive agents are used.. B and T lymphocyte attenuator (BTLA) is a newly discovered immunoglobulin superfamily inhibitory receptor, and Herpesvirus-entry mediator (HVEM), a member of the tumor necrosis factor receptor family, is the only ligand of BTLA.. Both BTLA and HVEM are widely expressed in B and T lymphocytes and other immune cells and play significant roles in the negative regulation of an immunoreaction. Saline:Article Title: Improved Osteogenesis by HVEM-Expressing Allogenic Bone Marrow-Derived Mesenchymal Stem Cells in an Immune Activation Condition and Mouse Femoral Defect Model Article Snippet: Th is pa pe r h as b ee n pe er ‐re vie we d an d ac ce pt ed fo r p ub lic at io n, b ut h as ye t t o un de rg o co py ed iti ng an d pr oo f c or re ct io n. Th e f in al pu bl ish ed ve rs io n m ay d iff er fr om th is pr oo f. Improved osteogenesis by HVEM‐expressing allogenic bone marrow‐derived mesenchymal stem cells in an immune activation condition and mouse femoral defect model Zhigang Rong1, Fei Zhang2, Zhengdong Wang1, Weifeng He3, Shiwu Dong1,4, Jianzhong Xu1, Fei Dai1 1Department of Orthopaedics, National & Regional United Engineering Laboratory, Southwest Hospital, Army Medical University, Chongqing, China.. 2Department of Orthopaedics, General hospital of Xin Jiang military region, Xinjiang, China.. 3Institute of Burn Research, State Key Laboratory of Trauma, Southwest Hospital, Army Medical University, Chongqing, China. Article Title: Improved Osteogenesis by HVEM-Expressing Allogenic Bone Marrow-Derived Mesenchymal Stem Cells in an Immune Activation Condition and Mouse Femoral Defect Model. Article Snippet: Use of allogeneic mesenchymal stem cells (allo-MSCs) in bone tissue engineering strategies can overcome the limitations associated with autologous MSCs, but unfortunately, the immunogenicity of allo-MSCs leads to a high rate of rejection, unless immunosuppressive agents are used.. B and T lymphocyte attenuator (BTLA) is a newly discovered immunoglobulin superfamily inhibitory receptor, and Herpesvirus-entry mediator (HVEM), a member of the tumor necrosis factor receptor family, is the only ligand of BTLA.. Both BTLA and HVEM are widely expressed in B and T lymphocytes and other immune cells and play significant roles in the negative regulation of an immunoreaction. |